Yunkang Group Limited (HKG:2325)
Hong Kong · Delayed Price · Currency is HKD 0.4600
+0.0150 (3.37%)
Sep 30, 2026, 4:08 PM HKT
Yunkang Group Market Cap
Yunkang Group has a market cap or net worth of 269.26 million as of October 1, 2026. Its market cap has decreased by -65.15% in one year.
Market Cap
269.26M
Enterprise Value
-820.77M
Revenue
624.49M
Ranking
n/a
PE Ratio
3.84
Stock Price
0.46
ChartMarket Cap Chart
Since May 18, 2022, Yunkang Group's market cap has decreased from 5.21B to 269.26M, a decrease of -94.83%. That is a compound annual growth rate of -49.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 269.26M | -53.54% |
| Dec 31, 2025 | 579.49M | -89.52% |
| Dec 31, 2024 | 5.53B | -25.83% |
| Dec 29, 2023 | 7.46B | -25.55% |
| Dec 30, 2022 | 10.01B | 92.14% |
| May 18, 2022 | 5.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WuXi XDC Cayman | 103.84B |
| Adicon Holdings | 3.46B |
| Mega Genomics | 1.59B |
| Kindstar Globalgene Technology | 910.37M |
| China Biotech Services Holdings | 517.14M |
| Biosino Bio-Technology and Science Incorporation | 464.51M |
| China NT Pharma Group Company | 389.09M |
| Zhong Ji Longevity Science Group | 305.59M |